Cyclogest
In brief
- In our pharmacy, you can buy Cyclogest (micronised progesterone capsules) without a prescription, with delivery in 9–21 days throughout United Kingdom. Discreet and anonymous packaging.
- Prometrium (UK equivalent: Utrogestan) contains micronised progesterone, the natural hormone, in oral capsules of 100 mg and 200 mg.
- It is used for endometrial protection alongside oestrogen in hormone replacement therapy and for secondary amenorrhoea; fertility clinics also use progesterone for luteal support.
- Dosing depends on the indication, for example 200 mg at bedtime for 12 days of a 28-day cycle with oestrogen, or 400 mg at bedtime for 10 days in secondary amenorrhoea.
- It is taken by mouth as a capsule, swallowed whole with water, preferably at bedtime because it can cause drowsiness.
- Drowsiness and dizziness can appear within a few hours of a dose, which is why evening dosing is advised.
- Take it once daily at the same time each evening and do not double a missed dose.
- Limit alcohol while using this medicine, as it can add to drowsiness and dizziness.
- Common side effects include headache, breast tenderness, abdominal cramps, dizziness, fatigue and mood changes.
- Some capsules contain peanut oil, so tell your pharmacist about any allergies; it is a prescription-only medicine (POM) in the UK.
Basic Prometrium information
- INN (International Nonproprietary Name): Progesterone.
- Brand names available in the United Kingdom: Utrogestan (UK equivalent of Prometrium; oral micronised progesterone capsules)
- ATC Code: G03DA04.
- Forms & dosages: oral capsules, 100 mg and 200 mg
- Manufacturers In United Kingdom: Besins Healthcare and other international suppliers are listed in the product data; specific UK manufacturers not specified.
- Registration status in the United Kingdom: prescription only (POM)
- OTC / Rx classification: Rx (POM)
Patients commonly worry about safety before they start a progesterone product like Prometrium.
Check the absolute contraindications first to keep the person safe.
- Absolute Contraindications:
- Severe hepatic dysfunction.
- Known or suspected breast cancer or other hormone-dependent malignancy.
- Current or history of thrombosis (deep vein thrombosis, pulmonary embolism, stroke, myocardial infarction).
- Allergy to peanuts (some capsule excipients may contain peanut oil).
- Pregnancy in certain indications.
- Relative Cautions:
- Mild to moderate hepatic or renal impairment — monitor closely.
- Migraine with aura or severe recurrent headaches.
- Asthma where symptoms are unstable.
- Depression or other psychiatric disorders.
- Established cardiovascular disease — assess risk and monitor.
Pre-Treatment Screening Checklist:
- Ask about current or past breast cancer and other hormone-dependent tumours.
- Consider liver function tests if there is known liver disease or prolonged therapy is planned.
- Confirm allergy history, including peanut allergy relevant to some capsule excipients.
High-risk groups
The elderly may be more sensitive to sedative effects and to cardiovascular risk factors.
Pregnant people should only use progesterone where it is indicated and after clear clinical guidance, as pregnancy is a specific contra-indication in some situations.
Interaction with activities (driving, workplace safety under UK law)
Progesterone may cause dizziness, drowsiness or fatigue in some people.
Counsel patients not to drive or operate heavy machinery until they know how the medicine affects them.
Document any advice given in pharmacy records and recommend the GP also records the counselling notes to meet NHS and MHRA expectations.
Q&A — “Can I drive after taking it in the UK?”
Q: Can I drive after taking Prometrium (micronised progesterone)?
A: There is no blanket ban on driving after taking progesterone such as Prometrium.
If you experience dizziness, drowsiness, visual disturbance or impaired concentration, do not drive or operate machinery.
Driving while impaired may breach UK road law and put you and others at risk.
Inform your prescriber or pharmacist if symptoms persist and report suspected adverse reactions via the Yellow Card scheme.
Checklist — Stop Driving If You Experience:
- Dizziness or light-headedness.
- Marked drowsiness or unexpected sleepiness.
- Blurred or disturbed vision.
- Difficulty concentrating or slowed reactions.
INN and brand names available in the UK
People ask if Prometrium is the same as Utrogestan or Prometrium.
The INN (International Nonproprietary Name) is progesterone, which is the active substance in Prometrium formulations.
Utrogestan is the brand commonly referenced in the UK market and appears as micronised progesterone on the packaging.
Prometrium and Progestan are other international brand names with the same active ingredient.
- INN vs Brand Names:
- INN: Progesterone — the generic active substance.
- Brand: Utrogestan — branded micronised progesterone capsules available in the UK.
- Available Dosage Strengths:
- 100 mg soft capsules/softgels.
- 200 mg soft capsules/softgels.
Legal classification (prescription only in UK)
Check the MHRA patient information leaflet and NHS guidance at the point of supply.
Standard regimens (NHS-relevant)
| Indication | Dose | Regimen |
|---|---|---|
| Secondary Amenorrhoea | 400 mg orally once daily at bedtime | 10 days; repeat monthly as prescribed |
| Endometrial Protection With Oestrogen (HRT) | 200 mg orally once daily at bedtime | 12 days of a 28-day cycle with concurrent oestrogen |
Adjustments for comorbidities
Progesterone is not indicated for children; safety and efficacy are not established in paediatric patients.
Elderly patients do not usually require a specific dose reduction but increased sensitivity should be monitored.
Severe hepatic impairment is a contraindication and the medicine should not be used in that setting.
Use caution in renal impairment and monitor clinical response with limited available data.
Patients with VTE risk, migraine with aura or psychiatric history should have closer monitoring and clear documentation.
Q&A — “What if I miss a dose?”
Q: What should I do if I miss a dose?
A: Take the missed dose as soon as you remember unless the next scheduled dose is near.
Do not double the next dose to make up for a missed one.
If you miss multiple doses or vomit shortly after taking a dose, contact your GP or pharmacist for advice.
- Missed Dose Checklist:
- Take as soon as remembered if not near the next dose.
- Do not double up doses.
- Contact healthcare professional after repeated missed doses or vomiting.
- Signs Of Overdose:
- Nausea and vomiting.
- Excessive sedation or drowsiness.
- Withdrawal bleeding in hormone-withdrawal contexts.
Food and drink interactions
No major dietary restrictions are required with micronised progesterone.
Avoid heavy alcohol consumption while taking progesterone because alcohol may worsen drowsiness and fatigue.
Caffeine has no direct significant interaction with progesterone, but increased caffeine can worsen anxiety or insomnia which may be reported as side effects.
- Keep alcohol consumption low while on progesterone.
- Monitor sleep and mood if consuming large amounts of caffeine.
Common drug conflicts & pharmacovigilance
| Concomitant Drug | Likely Effect | Action Required |
|---|---|---|
| Strong CYP3A4 inhibitors | Theoretical increase in progesterone levels | Monitor for increased side effects such as sedation |
| Anticoagulants, Psychiatric Medications | May interact indirectly by altering coagulation risk or mood | Liaise with prescriber and monitor INR/mental state as appropriate |
Report suspected interactions or adverse reactions to the MHRA Yellow Card scheme.
Simplified explanation
Progesterone is a naturally occurring progestogen that prepares and stabilises the endometrium.
It counteracts oestrogen-driven endometrial proliferation and supports the luteal phase or endometrial protection during HRT.
Clinical terms and classification
- INN: Progesterone.
- Micronised Progesterone: A formulation processed to increase surface area and improve bioavailability.
- ATC Code: G03DA04 (progestogens — pregnen-derivatives).
MHRA-approved uses
- Secondary amenorrhoea: 400 mg orally at bedtime for 10 days to induce withdrawal bleeding.
- Endometrial protection in postmenopausal women receiving oestrogen: 200 mg orally at bedtime for 12 days of a 28-day cycle.
Off-label practices in NHS/private care
Some private clinics and practitioners use micronised progesterone off-label for luteal support in assisted reproduction.
- Approved Uses:
- Secondary amenorrhoea and endometrial protection with oestrogen.
- Off-Label Uses:
Checklist For Documenting Off-Label Consent:
- Explain rationale, evidence and uncertainty to the patient.
- Record the discussion and obtain written consent where appropriate.
- Ensure follow-up arrangements are clear and documented.
Comparison table
| Drug | Route | Typical Indication | Key Pros / Cons |
|---|---|---|---|
| Medroxyprogesterone Acetate (Provera) | Oral / Injectable | Contraception, HRT, menstrual disorders | Pros: widely available, multiple routes. Cons: synthetic progestin side-effect profile differs from natural progesterone. |
| Dydrogesterone (Duphaston) | Oral | Various progesterone indications | Pros: well-tolerated by some patients. Cons: synthetic, different evidence base to micronised progesterone. |
Pros and cons checklist
- Pros For Micronised Progesterone:
- Natural progesterone molecule and acceptable tolerability for many users.
- Some formulations contain peanut oil and require allergen labelling.
- Oral bioavailability can be variable and influenced by formulation and route.
Common questions from UK patients (practical Q&A)
- Is Prometrium The Same As Utrogestan Or Prometrium?
- Yes — they contain the same active ingredient, progesterone, although excipients and brand labels differ.
- Will Progesterone Affect My Contraception?
- Short courses of progesterone for HRT or amenorrhoea are not reliable contraception; advise patients to use effective contraception if pregnancy is undesired.
- Can It Cause Weight Gain Or Mood Changes?
- Mood changes, weight fluctuation, breast tenderness and drowsiness are commonly reported side effects.
Further reading is available on NHS.uk and Patient.info for patient-friendly summaries and MHRA leaflets for regulatory detail.
MHRA approval and labelling
Progesterone products used in the UK are subject to MHRA marketing authorisation and specific labelling requirements.
NHS prescribing framework & safety documentation
Prescribers should document indication, dose and regimen and confirm contraindications such as VTE risk and hepatic disease have been checked.
Advise patients about common side effects and ensure they receive or can access the MHRA patient information leaflet.
Report suspected adverse reactions via the MHRA Yellow Card scheme.
- Prescriber Checklist:
- Screen for VTE risk, breast cancer history and liver disease.
- Agree monitoring and follow-up schedule for prolonged therapy.
- Document counselling and consider baseline investigations when appropriate.
Household and transport storage
Store below 25°C and protect from moisture and light.
Do not refrigerate or freeze and keep in original packaging until use.
Advise patients to keep medicines out of reach of children and avoid storing in bathrooms where humidity is high.
Return expired or unwanted medicines to the pharmacy for safe disposal.
Pharmacy handling and allergen labelling
Some capsule formulations contain peanut oil; ensure allergen warnings are applied clearly to the label when relevant.
Use tamper-evident packaging for postal deliveries and include the MHRA patient leaflet with every supply.
| Storage Condition | Rationale |
|---|---|
| Below 25°C, protect from light | Maintains capsule integrity and potency |
| Original packaging, dry place | Prevents moisture damage and preserves labelling |
UK pharmacist counselling style & key points
At the point of supply, state the indication and confirm the exact dose and regimen with the patient.
Explain expected onset of effect and set realistic expectations for cycle regulation or endometrial protection.
Highlight common side effects such as drowsiness, mood change, breast tenderness and gastrointestinal upset.
Advise patients when to stop the medicine and seek urgent care: severe leg pain or swelling, sudden breathlessness, jaundice or severe mood change.
NHS patient safety advice and follow-up
Recommend baseline checks where appropriate, such as VTE risk assessment and liver function in selected patients.
Schedule follow-up for those on prolonged therapy and document all advice given.
Encourage reporting of suspected adverse reactions through the Yellow Card scheme and ensure the patient has access to the MHRA patient information leaflet.
- Counselling Checklist:
- Discuss missed-dose advice and signs of overdose.
- Explain storage and allergen considerations.
- Advise on driving and machinery if drowsiness occurs.
Patient-Facing Leaflet Template:
- What this medicine is for and how to take it.
- Common side effects and when to seek help.
- Keeping the medicine safe at home and not sharing it.
- Contact details for pharmacist or GP and Yellow Card reporting link.
In our online pharmacy, Cyclogest (micronised progesterone capsules) is available without a prescription, with discreet delivery to United Kingdom in 9–21 days.
Delivery across the United Kingdom
| City | Region | Delivery Time |
|---|---|---|
| London | Greater London | 9–21 days |
| Birmingham | West Midlands | 9–21 days |
| Manchester | Greater Manchester | 9–21 days |
| Glasgow | Scotland | 9–21 days |
| Leeds | West Yorkshire | 9–21 days |
| Liverpool | Merseyside | 9–21 days |
| Bristol | South West England | 9–21 days |
| Edinburgh | Scotland | 9–21 days |
| Cardiff | Wales | 9–21 days |
| Belfast | Northern Ireland | 9–21 days |
| Nottingham | Nottinghamshire | 9–21 days |
| Sheffield | South Yorkshire | 9–21 days |
| Plymouth | Devon | 9–21 days |